AM from mice that received an inhaled adenovirus vectored vaccine undergo trained immunity mediated by IFN-γ resulting in elevated MHC-II expression, enhanced cytokine production, and protection against specific and non-specific infection challenges (Yao et al., 2018; D’Agostino et al., 2020). The gene discussed is IFNG; the disease is infection.